The unique medical research facility, which was built in collaboration with NHS Greater Glasgow and Clyde (NHSGGC) and with £16m funding from the Medical Research Council and Glasgow City Region City Deal, was opened by the Chief Executive Designate of UK Research and Innovation (UKRI), Professor Sir Mark Walport.
ICE brings together world-leading research, cutting edge technology and international business investment under one roof and will act as a hub for translating science into economic and patient benefits for Glasgow, Scotland and the UK.
The project will bring 396 new high-value jobs to the city over a seven year period and has been independently assessed to contribute £88m to the local economy.
With aims to become a global centre of excellence for precision medicine, the building is already home to Scotland's first 7 Tesla MRI scanner - the first of its kind in the UK in a clinical setting. The scanner will be a focus of research for clinical and non-clinical academic imaging specialists and clinical physics expertise.
The state of the art building will also house the Clinical Innovation Zone, a space dedicated to biomedical companies which will facilitate industry collaborations and the development of innovative healthcare technology. There will also be a further floor of neuro operating theatres, which will be funded by the NHS GGC.
The Clinical Innovation Zone has already attracted international small and medium-sized enterprises (SMEs) from around the world, including Germany and Singapore. Also in attendance at the opening was the Singapore High Commissioner, Her Excellency Ms FOO Chi Hsia.
ICE is one of three projects in the Glasgow City Region City Deal's Innovation and Growth theme, alongside MediCity and Tontine, Centre for Business Incubation and Development in the Merchant City.
Read more: http://bit.ly/2ogEl8f
